Wah‐Kheong Chan

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

Thomas Karlas, David Petroff, M. Sasso et al. · Journal of Hepatology · 2016 · 1.2K citations · Full text

Controlled Attenuation Parameter, Clinical Endpoint, Laboratory Medicine +3

FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study

Philip N. Newsome, M. Sasso, Jonathan J Deeks et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 729 citations · Full text

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9

A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis

Wah‐Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva · Clinical Gastroenterology and Hepatology · 2017 · 240 citations

Hepatology, Nonalcoholic Fatty Liver Disease, Medicine +8

Global burden of metabolic diseases, 1990–2021

Huai Zhang, Xiaodong Zhou, Michael D. Shapiro et al. · Metabolism · 2024 · 240 citations

Obesity, Metabolic Syndrome, Global Burden +10